SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-106991
Filing Date
2024-04-23
Accepted
2024-04-23 16:08:55
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d703012ddefa14a.htm DEFA14A 11665
2 GRAPHIC g703012g51c30.jpg GRAPHIC 197088
3 GRAPHIC g703012g70r00.jpg GRAPHIC 116505
  Complete submission text file 0001193125-24-106991.txt   444620
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38938 | Film No.: 24864892
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)